Wang et al. discovered that the overexpression of PTEN in podocytes could protect the kidneys from the impact of hyperglycemia in vivo, suggesting that targeting PTEN may be a novel and promising therapeutic strategy for the treatment of DN [56]. This evidence concerns the gene PTEN and liver dysplastic nodule.